Replies to post #124825 on Biotech Values

[mcbio]

IND in June for pain? 797 finished phase 2 in acute pain setting in 2008.

Right. It's an additional trial that was commenced for 797, not an IND that was filed to begin a new trial. The IND would have presumably been for the asthma drug now in Phase 1.